USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Arzneimittel GMBH Apotheker Vetter & Co. Ravensburg

USPTO PatentsView assignee record - 10 granted patents across 12 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company

The verdict

According to USPTO PatentsView, Arzneimittel ranks #25,787 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 12 technology areas.

#25,787
of 49,997 US assignees by volume
37th percentile
by Innovation Score (31.2/100)
17.8
avg claims per patent
-89%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25787 · Foreign Corporation #25,787 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 10 grants
  • MID-PACK #25,787/49,997
  • PHOTO-FINISH Arista Cereal PTY
  • CPC-FOCUS A61M · 12 areas
  • INNOV-THIN 31.2/100
  • CLAIMS-RICH 17.8 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -89% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Arista Cereal Technologies PTY Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Arzneimittel’s 31.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Arzneimittel

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Arzneimittel's Innovation Score is 31.2/100 (37th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Arzneimittel?

Each dot is one of Arzneimittel’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Arzneimittel’s own 17.8 claims/patent is ABOVE the 11.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Arzneimittel vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 9.99.91010.1 0510152025 Granted patents (volume) Avg claims / patent Arista Cereal Technologies PTY Limited - 10, 18.7Arista Cereal PTYARK Crystal, LLC - 10, 11.8ARK CrystalArrow Acquisition, LLC - 10, 3.1Arrow AcquisitionArtic Investments S.A. - 10, 1.9Artic InvestmentsAS Strömungstechnik GmbH - 10, 13AS Strömungstechn…Ascendis Pharma Endocrinology Division A/S - 10, 19.8Ascendis Pharma E…Ascendo Medienagentur AG - 10, 2.2Ascendo Medienage…Asymchem Laboratories (FUXIN) Co., Ltd. - 10, 11.2Asymchem Laborato…Arzneimittel GMBH Apotheker Vetter & Co. Ravensburg - 10, 17.8Arzneimittel Apot…
Arzneimittel vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Arzneimittel's grants concentrate

Arzneimittel GMBH Apotheker Vetter & Co. Ravensburg is a focused PatentsView assignee: 12 CPC subclasses with 70% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2016. By volume, Arzneimittel sits between Arista Cereal Technologies PTY Limited and Asymchem Laboratories (FUXIN) Co., Ltd..

Who files at Arzneimittel's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Arzneimittel holds 10 patents at rank #25,711, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Arzneimittel

By rank, the assignees closest to #25,711 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Arzneimittel's primary technology class.

Arzneimittel's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 37th percentile higher than 37% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20152016201720192021 1
USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Arzneimittel GMBH Apotheker Vetter & Co. Ravensburg patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 20.0%
2016 1 10.0%
2017 3 30.0%
2019 3 30.0%
2021 1 10.0%

Which technologies does Arzneimittel GMBH Apotheker Vetter & Co. Ravensburg patent most?

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Arzneimittel GMBH Apotheker Vetter & Co. Ravensburg's patent record in context - here's where to go next.

  • Arzneimittel GMBH Apotheker Vetter & Co. Ravensburg's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 70% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #25,787 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Arzneimittel GMBH Apotheker Vetter & Co. Ravensburg against Arista Cereal Technologies PTY Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 31.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.